Breaking News:
Akita Nasal Technology Published in Leading Peer-Reviewed Journal
Read More
HOME | ABOUT US | ALEX REVELOS

Alex Revelos

Founding CEO

Alex Revelos is the founding chief executive officer of Akita Biosciences. An engineer by training, Alex has spent his career driving the adoption of novel healthcare technologies with experience spanning R&D, marketing, and management.

Before Akita Biosciences, Alex spent six years at Sarnova (acquired by Investor AB), where he managed a portfolio of differentiated respiratory care and anesthesia products in the hospital market. Leveraging his commercial acumen, he helped to drive annual revenue from $20M to $60M.

Alex realized the magnitude of the global burden of respiratory diseases and the positive impact of new technologies. Based on emerging science of the nose and individual consumers becoming more diligent about their health, he wanted to build a company focused on solutions in the consumer-facing portion of the respiratory care market.

Alex earned his master’s in Engineering and Management from MIT’s School of Engineering and the Sloan School of Management. He was the inaugural teaching assistant for Harvard-MIT course HST 962: Medical Product Development and Translational Biomedical Research, developed by Professor Michael Cima. Alex has a BS in Biomedical Engineering from Wright State University.

HOME | ABOUT US | ALEX REVELOS

Alex Revelos

CEO

Alex Revelos is the founding chief executive officer of Akita Biosciences. An engineer by training, Alex has spent his career driving the adoption of novel healthcare technologies with experience spanning R&D, marketing, and management.

Before Akita Biosciences, Alex spent six years at Sarnova (acquired by Investor AB), where he managed a portfolio of differentiated respiratory care and anesthesia products in the hospital market. Leveraging his commercial acumen, he helped to drive annual revenue from $20M to $60M.

Alex realized the magnitude of the global burden of respiratory diseases and the positive impact of new technologies. Based on emerging science of the nose and individual consumers becoming more diligent about their health, he wanted to build a company focused on solutions in the consumer-facing portion of the respiratory care market.

Alex earned his master’s in Engineering and Management from MIT’s School of Engineering and the Sloan School of Management. He was the inaugural teaching assistant for Harvard-MIT course HST 962: Medical Product Development and Translational Biomedical Research, developed by Professor Michael Cima. Alex has a BS in Biomedical Engineering from Wright State University.

An innovative health & wellness company developing science-backed nasal therapies to prevent airborne infections
About
About Us
Science
See our Platform
Contact
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Join our subscribers lists to get the latest news and updates delivered directly to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

SUBSCRIBE TO OUR NEWSLETTER

Join our subscribers lists to get the latest news and updates delivered directly to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure any disease

SUBSCRIBE TO OUR NEWSLETTER

Join our subscribers lists to get the latest news and updates
delivered directly to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Contact Us
Contact Us
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure any disease.

SUBSCRIBE TO OUR NEWSLETTER

Join our subscribers lists to get the latest news and updates delivered directly to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© Akita Biosciences 2024. All Rights Reserved.